To study response to thiopurines (a drug used for treatment in Inflammatory Bowel Disease including Ulcerative colitis and Crohns Disease)
- Conditions
- Health Condition 1: K50- Crohns disease [regional enteritis]Health Condition 2: K51- Ulcerative colitis
- Registration Number
- CTRI/2020/08/027444
- Lead Sponsor
- Dayanand Medical College and Hospital Ludhiana
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients with Inflammatory Bowel Disease receiving thiopurines
2.Patientâ??s demonstration of understanding of study requirements and treatment procedures, willingness to comply with all protocol-required evaluations
1.Pregnant/lactating female
2.History or other evidence of severe illness or any other conditions that would make the patient, in the opinion of the investigator, unsuitable for the study (such as poorly controlled psychiatric disease, HIV, significant co-morbidities like advanced coronary artery disease, etc.)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method